Oculis Holding AG (OCS) Operating Expenses (2022 - 2026)

Oculis Holding AG's (OCS) quarterly Operating Expenses came in at -$28.0 million in Q1 2026, down 24.32% year-on-year from -$37.0 million in Q1 2025, and down 6.4% quarter-over-quarter from -$26.3 million in Q4 2025.

Oculis Holding AG (OCS) Operating Expenses (2022 - 2026) Analysis & Trends

Oculis Holding AG's Operating Expenses history runs 5 years deep, the most recent figure standing at -$28.0 million for Q1 2026.

  • On a quarterly basis, Operating Expenses fell 24.32% year-over-year to -$28.0 million in Q1 2026; TTM through Mar 2026 was -$25.8 billion, a 21.24% decrease from a year earlier, with the FY2025 full-year figure at -$100.0 million, down 19.0% from the prior year.
  • Operating Expenses declined to -$28.0 million in Q1 2026 per OCS's latest filing, from -$26.3 million in the prior quarter.
  • Across five years, Operating Expenses topped out at -$7.3 million in Q3 2022 and bottomed at -$25.7 billion in Q3 2025.
  • The 5-year median for Operating Expenses is -$21.1 million (2024), against an average of -$2.9 billion.
  • Biggest YoY gain for Operating Expenses was 63.43% in 2024; the steepest drop was 141836.6% in 2024.
  • Year by year, Operating Expenses stood at -$11.8 million in 2022, then slipped by 18.6% to -$13.9 million in 2023, then sank by 41.32% to -$19.7 million in 2024, then slumped by 33.61% to -$26.3 million in 2025, then retreated by 6.4% to -$28.0 million in 2026.
  • Per Business Quant, the three latest OCS Operating Expenses figures stand at -$28.0 million (Q1 2026), -$26.3 million (Q4 2025), and -$25.7 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -28.01 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 15.76 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.10 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.85 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 32.68 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -919.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 445.22 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 898.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -28.01 Mn
Dec 31, 2025 -26.33 Mn
Sep 30, 2025 -25.68 Bn
Jun 30, 2025 -25.40 Mn
Mar 31, 2025 -22.53 Mn
Dec 31, 2024 -19.71 Mn
Sep 30, 2024 -21.18 Bn
Jun 30, 2024 -25.13 Mn
Mar 31, 2024 -17.82 Mn
Dec 31, 2023 -13.94 Mn
Sep 30, 2023 -14.92 Mn
Jun 30, 2023 -12.23 Mn
Mar 31, 2023 -48.71 Mn
Dec 31, 2022 -11.76 Mn
Sep 30, 2022 -7.33 Mn
Jun 30, 2022 -9.84 Mn